Li, Chiang J.,Li, Youzhi,Borodyansky, Laura,Gao, Yuan,Leggett, David,Kerstein, David P.
申请号:
AU2016249158
公开号:
AU2016249158A1
申请日:
2016.04.18
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
Methods comprising administration of and kits comprising at least one compound of formula (I); and at least one additional anti-cancer therapy chosen from panitumumab, cetuximab, capecitabine, CAPOX, regorafenib, and FOLFOX.